Supplementation with the Prebiotic High-Esterified Pectin Improves Blood Pressure and Cardiovascular Risk Biomarker Profile, Counteracting Metabolic Malprogramming.
Francisco García-CarrizoSebastiá GalmésCatalina PicóAndreu PalouAna María RodríguezPublished in: Journal of agricultural and food chemistry (2022)
Supplementation with the prebiotic pectin is associated with beneficial health effects. We aimed to characterize the cardioprotective actions of chronic high-esterified pectin (HEP) supplementation (10%) in a model of metabolic malprogramming in rats, prone to obesity and associated disorders: the progeny of mild calorie-restricted dams during the first half of pregnancy. Results show that pectin supplementation reverses metabolic malprogramming associated with gestational undernutrition. In this sense, HEP supplementation improved blood pressure, reduced heart lipid content, and regulated cardiac gene expression of atrial natriuretic peptide and lipid metabolism-related genes. Moreover, it caused an elevation in circulating levels of fibroblast growth factor 21 and a higher expression of its co-receptor β-klotho in the heart. Most effects are correlated with the gut levels of beneficial bacteria promoted by HEP. Therefore, chronic HEP supplementation shows cardioprotective actions, and hence, it is worth considering as a strategy to prevent programmed cardiometabolic alterations.
Keyphrases
- blood pressure
- gene expression
- heart failure
- atrial fibrillation
- type diabetes
- metabolic syndrome
- weight loss
- pregnant women
- poor prognosis
- insulin resistance
- transcription factor
- hypertensive patients
- left ventricular
- pregnancy outcomes
- cell wall
- preterm birth
- left atrial
- drug induced
- long non coding rna
- adipose tissue
- catheter ablation